ABEO vs WFC · rev $3.5M vs P/E 15, rev $83.70B
Abeona Therapeutics Inc (ABEO) versus Wells Fargo & Company (WFC) — a side-by-side from cached financials, not a winner call.
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
Wells Fargo & Company (WFC) is a banks - diversified company listed on US. It is led by Charlie Scharf.
Latest reported ABEO revenue for 2023-12-31 was $3.5M. Net income was -$54.2M. Revenue was up 147.5% from 2022-12-31 to 2023-12-31. ABEO currently screens at market cap $301.8M.
Latest reported WFC revenue for 2025-12-31 was $83.70B. Net income was $21.34B. Revenue was up 1.7% from 2024-12-31 to 2025-12-31. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
ABEO currently screens at market cap $301.8M. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
Not investment advice. Open the ABEO and WFC stock pages for the full models.
Not investment advice.